Recently added

Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma

Hecht, Joel; Digklia, Antonia; Rottey, Sylvie; Oberoi, Arjun; GARRALDA, Elena; Chon, Hong Jae (Oxford University Press, 2025-03)

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2

Eng, Cathy; Elez, Elena; Dasari, Arvind; Lonardi, Sara; Garcia-Carbonero, Rocio; Yoshino, Takayuki (Oxford University Press, 2025-03)

The impact of a high fat diet and platelet activation on pre-metastatic niche formation

Hergueta-Redondo, Marta; Sánchez-Redondo, Sara; Hurtado, Begoña; Santos, Vanesa; Pérez-Martínez, Manuel; Ximénez-Embún, Pilar (Nature Portfolio, 2025-04-02)

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development

Navarro-Garcia, Daniel; Beets-Tan, Regina; Blomqvist, Lennart; Bodalal, Zuhir; Marcos Morales, Adrià; DEANDREIS, Desiree'; Perez-Lopez, Raquel (Elsevier, 2025-06)

Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence

Cabeza-Segura, Manuel ; Ferreira, Rui M.; Barros, Rita; Santos-Antunes, João; Groen - van Schooten, Tessa Suzanne; Martinez Ciarpaglini, Carolina; Ruiz Pace, Fiorella; Díez García, Marc; Alsina, Maria; Dienstmann, Rodrigo (Nature Portfolio, 2025-05-18)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2

The impact of a high fat diet and platelet activation on pre-metastatic niche formation

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development

Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma ﻿

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2 ﻿

The impact of a high fat diet and platelet activation on pre-metastatic niche formation ﻿

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development ﻿

Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence ﻿

Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2

The impact of a high fat diet and platelet activation on pre-metastatic niche formation

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development

Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence